Thaxter Sharp

Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers, Stephanie Culler PhD, and Steve Van Dien PhD.

Capria Ventures is a Global South specialist venture capital firm investing in applied Generative AI, connecting founders into a uniquely collaborative network. Capria activates strong relationships between hundreds of founders and leading local VC firms in the tech hubs of the Global South - from Sao Paulo to Lagos to Bangalore to Jakarta. Capria brings state-of-the-art venture capital innovation combined with global best practices of sustainable ESG management to select and manage its portfolio of startups serving the fastest-growing economies of the world. Capria manages assets over USD 188M. Capria has offices in Seattle, Bangalore, Nairobi, and Washington DC. Investors and catalytic supporters include World Banks International Finance Corporation (IFC), Bill Gates (in a personal capacity), Ceniarth, Crystal Springs Foundation, Sorenson Impact Foundation, Unitus Labs, Lemelson Foundation, Mohandas Pai, and other leading impact investors.

Persephone is pioneering the use of synthetic biology for microbial products that impact patient and infant health. We are building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers, Stephanie Culler PhD, and Steve Van Dien PhD.

Capria Ventures is a Global South specialist venture capital firm investing in applied Generative AI, connecting founders into a uniquely collaborative network. Capria activates strong relationships between hundreds of founders and leading local VC firms in the tech hubs of the Global South - from Sao Paulo to Lagos to Bangalore to Jakarta. Capria brings state-of-the-art venture capital innovation combined with global best practices of sustainable ESG management to select and manage its portfolio of startups serving the fastest-growing economies of the world. Capria manages assets over USD 188M. Capria has offices in Seattle, Bangalore, Nairobi, and Washington DC. Investors and catalytic supporters include World Banks International Finance Corporation (IFC), Bill Gates (in a personal capacity), Ceniarth, Crystal Springs Foundation, Sorenson Impact Foundation, Unitus Labs, Lemelson Foundation, Mohandas Pai, and other leading impact investors.

First Bight Ventures is the first early stage fund that is dedicated to synthetic biology start-ups. We see the potential of syn-bio across broad range of verticals that could truly transform the world for a sustainable future. These verticals include (but not limited to) energy, chemical, agriculture, medicine, heavy industries and consumer goods.

Zetta invests in intelligent enterprise software. We partner with companies building software that learns from data to analyze, predict and prescribe outcomes. We lead or co-lead $1-5M funding rounds.